- 54
- 3 058
Global CEO Initiative on Alzheimer's Disease
Приєднався 18 тра 2021
Founded in 2013, The Global CEO Initiative on Alzheimer’s Disease (CEOi) brings business leadership to the fight against Alzheimer’s - a growing pandemic. The CEOi believes that as the world rapidly ages, we need visionary, coordinated, goal-oriented and cross-sector collaboration to solve our greatest public health challenges.
The Case for Regulatory Approval of Amyloid Lowering Immunotherapies in Alzheimer’s Disease
A conversation with Dr. Dennis Selkoe and George Vradenburg.
The full paper can be found online here: alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14342?af=R
The full paper can be found online here: alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14342?af=R
Переглядів: 156
Відео
CEOi Blood-Based Biomarker Workgroup, featuring Michelle Mielke and Chi Udeh-Momoh
Переглядів 982 місяці тому
CEOi Blood-Based Biomarker Workgroup, featuring Michelle Mielke and Chi Udeh-Momoh
CEOi BBM Workgroup, Suzanne Schindler feature
Переглядів 5406 місяців тому
CEOi BBM Workgroup, Suzanne Schindler feature
AD/PD | March 2024 | BBM Workgroup Panel Discussion
Переглядів 1059 місяців тому
CEOi held a panel discussion at the International Conference on Alzheimer's and Parkinson Disease (AD/PD) 2024, "Exploring Blood-Based Biomarker Adoption: Insights from Real-World Practice." The discussion was moderated by George Vradenburg, Convener of CEOi, and featured Ana Pereira, Mount Sinai; Robert Perneczky, University of Munich; and Richard Batrla, Eisai.
AAGP | March 2024 | BBM Workgroup Symposium
Переглядів 219 місяців тому
The Blood-Based Biomarker Workgroup held a symposium at the American Association for Geriatric Psychiatry Annual Meeting 2024. The title of the symposium was Unleashing Diagnostic Innovation: Clinical Implementation of Blood-Based Biomarkers for Alzheimer's Disease
Highlights | John Dwyer | AAIC BBM Panel | July 2023
Переглядів 910 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Ethical Aspects of BBMs | Patient Journey | AAIC BBM Panel | July 2023 | Q&A | Q3
Переглядів 910 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Rigor of Evidence | Comparing BBMs to PET & CSF | AAIC BBM Panel | July 2023 | Q&A | Q2
Переглядів 510 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Standards of Truth for BBMs | Sensitivity & Specificity | AAIC BBM Panel | July 2023 | Q&A | Q1
Переглядів 1010 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Closing Thoughts (Pre-Q&A) | John Dwyer | AAIC BBM Panel | July 2023 | Part 5
Переглядів 110 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Highlights | Michelle Mielke & Chi Udeh Momoh | AAIC BBM Panel | July 2023
Переглядів 1110 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
BBM Workstream B | Michelle Mielke & Chi Udeh Momoh | AAIC BBM Panel | July 2023 | Part 4
Переглядів 2210 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Highlights | Suzanne Schindler | AAIC BBM Panel | July 2023
Переглядів 1710 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
BBM Workstream A | Suzanne Schindler | AAIC BBM Panel | July 2023 | Part 3
Переглядів 2010 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Introduction to the BBM Workstreams | John Dwyer | AAIC BBM Panel | July 2023 | Part 2
Переглядів 1010 місяців тому
Please follow us on social media and check our website for updates! Read more about CEOi's Blood-Based Biomarker Workgroup here: www.usagainstalzheimers.org/blood-based-biomarker-workgroup
Introduction to CEOi | Drew Holzapfel | AAIC BBM Panel | July 2023 | Part 1
Переглядів 1810 місяців тому
Introduction to CEOi | Drew Holzapfel | AAIC BBM Panel | July 2023 | Part 1
CEOi’s Blood-Based Biomarker Workgroup Meeting at AAIC 2023
Переглядів 447Рік тому
CEOi’s Blood-Based Biomarker Workgroup Meeting at AAIC 2023
Lausanne VIII Day 4: David Bloom, Harvard University
Переглядів 612 роки тому
Lausanne VIII Day 4: David Bloom, Harvard University
Lausanne VIII Day 4: Donata Meroni, European Commission
Переглядів 272 роки тому
Lausanne VIII Day 4: Donata Meroni, European Commission
Lausanne VIII Day 3: Trish Vradenburg Memorial Lecture, Be Trish
Переглядів 92 роки тому
Lausanne VIII Day 3: Trish Vradenburg Memorial Lecture, Be Trish
Lausanne VIII Day 4: Payer and HTA Perspectives on Real-World Evidence Requirements and Standards
Переглядів 142 роки тому
Lausanne VIII Day 4: Payer and HTA Perspectives on Real-World Evidence Requirements and Standards
Lausanne VIII Day 4: Adopting New Value Approaches in Alzheimer's
Переглядів 242 роки тому
Lausanne VIII Day 4: Adopting New Value Approaches in Alzheimer's
Lausanne VIII Day 3: The Lived Experience of Alzheimer's
Переглядів 62 роки тому
Lausanne VIII Day 3: The Lived Experience of Alzheimer's
Lausanne VIII Day 3: Exploring the Promise of Novel Therapeutic Approaches
Переглядів 12 роки тому
Lausanne VIII Day 3: Exploring the Promise of Novel Therapeutic Approaches
Lausanne VIII Day 3: Building from First-in-Class Treatments
Переглядів 152 роки тому
Lausanne VIII Day 3: Building from First-in-Class Treatments
Lausanne VIII Day 3: The Evolving Regulatory Landscape: Ensuring Excellence and Innovation
Переглядів 172 роки тому
Lausanne VIII Day 3: The Evolving Regulatory Landscape: Ensuring Excellence and Innovation
Lausanne VIII Day 2: High-Tech Meets High-Touch: The Future of Professional Home Care
Переглядів 12 роки тому
Lausanne VIII Day 2: High-Tech Meets High-Touch: The Future of Professional Home Care
Lausanne VIII Day 2: Lessons from the Davos Alzheimer's Collaborative
Переглядів 92 роки тому
Lausanne VIII Day 2: Lessons from the Davos Alzheimer's Collaborative